Latvia - Beta Blocking Medicine Use
Since 2014, Latvia Beta Blocking Medicine Use jumped by 4% year on year. In 2019, the country was number 8 comparing other countries in Beta Blocking Medicine Use at 56.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Latvia is overtaken by Czech Republic, which was number 7 with 62.2 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Estonia with 55.2 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Germany ranked the highest with 81.9 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, +2.1% versus 2018. Lithuania, Belgium and Hungary respectively ranked number 2, 3 and 4 in this ranking. Turkey witnessed the best average annual growth at +5% per year, while Chile was the worst growing country at -4.9% per year.
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 56.50 |
| 2018 | 52.80 |
| 2017 | 52.10 |
| 2016 | 49.70 |
| 2015 | 48.10 |
How does Latvia rank in Beta Blocking Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Germany
|
82 | 2019 | +2.1 % | -1.6 % | View data | |
| 2 |
#2
Lithuania
|
77 | 2019 | +3.4 % | +1.6 % | View data | |
| 7 |
#7
Czech Republic
|
62 | 2019 | +1.1 % | -0.8 % | View data | |
| 8 |
#8
Latvia
|
57 | 2019 | +7.0 % | +4.0 % | View data | |
| 9 |
#9
Estonia
|
55 | 2019 | +1.5 % | +4.0 % | View data | |